Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Pengzhou, Sichuan, Chinacn-kanghong.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Sichuan Jishengtang Pharmaceutical has achieved regulatory approval in China for several products including Keluoxin Capsule for diabetes mellitus and ShuGanJieYuJiaoNang. Wujia Yizhi Granules are in Phase 3 development for Alzheimer's disease. The company focuses on both chemical medicines and traditional Chinese patent medicines with a track record of successful product approvals since at least May 2018.
- Therapeutic areas
- PsychiatryEndocrinologyNeurologyHematology
- Modalities
- Small moleculesTraditional patent medicine/TCMHerbal medicines
- Industry
- Biotech
Beyond the preview
Go deeper on Sichuan Jishengtang Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sichuan Jishengtang Pharmaceutical Co., Ltd..